BBS7 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 9.85139969600368E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.48529999999914E-05 |
Normal-vs-Stage2 |
3.604900E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.378800E-03 |
Stage1-vs-Stage2 |
8.173200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.886000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.778200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.90490000229593E-08 |
Normal-vs-AfricanAmerican |
1.0073999999749E-06 |
Normal-vs-Asian |
3.065600E-02 |
Caucasian-vs-AfricanAmerican |
9.844800E-01 |
Caucasian-vs-Asian |
6.730000E-01 |
AfricanAmerican-vs-Asian |
5.228000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.552480E-04 |
Normal-vs-Female |
3.14450000005184E-06 |
Male-vs-Female |
9.652000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.338700E-03 |
Normal-vs-Extreme_Weight |
9.9410000000022E-05 |
Normal-vs-Obese |
8.537300E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.638200E-01 |
Normal_Weight-vs-Obese |
2.687000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.985000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.490600E-01 |
Normal-vs-Age(41-60Yrs) |
1.198810E-03 |
Normal-vs-Age(61-80Yrs) |
2.93090000003104E-06 |
Normal-vs-Age(81-100Yrs) |
4.546600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.204000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.168400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.586600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.155400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.041600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.115000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.769200E-01 |
Normal-vs-Grade 3 |
2.578000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.156600E-01 |
Grade 2-vs-Grade 4 |
3.769200E-01 |
Grade 3-vs-Grade 4 |
2.578000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.86989999986886E-07 |
Normal-vs-N1 |
1.690450E-02 |
N0-vs-N1 |
1.481440E-01 |
|
|